Supplementation With GKEX Sports Probiotic Combo for Muscle Gain and Fat Loss Assessment
NCT ID: NCT05909475
Last Updated: 2023-06-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
52 participants
INTERVENTIONAL
2022-07-04
2022-12-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
To Explore the Effects of Different Training Periods and Dietary Pattern on the Gut Microbiota, Metabolites and Protein Expression Levels of Strength and Endurance Athletes and to Find Relevant Biological Indicators.
NCT04710667
The Effect of Probiotics and Vitamin D Supplementation on Sport Performance in MMA Athletes.
NCT04759729
The Effects of L-arginine Supplementation on Anaerobic Exercise Performance
NCT06475391
Evaluation of the Effects of a Novel Dietary Microalgae Based Ingredient on Muscle Recovery and Endurance Capacity
NCT05760742
Effects of a Multi-Ingredient Pre-Workout Supplement on Body Composition, Performance, Muscular Properties, and Wellbeing in Adults.
NCT05769088
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo
The placebo capsule contains microcrystalline cellulose, 2 caps daily use.
Placebo
The placebo capsule contains microcrystalline cellulose, 2 caps daily use.
GKEX
GKEX group. Probiotic capsules contain 10 billion CFU (colony forming units) of GKEX, , 2 caps daily use.
GKEX
GKEX group. Probiotic capsules contain 10 billion CFU (colony forming units) of GKEX, , 2 caps daily use.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
GKEX
GKEX group. Probiotic capsules contain 10 billion CFU (colony forming units) of GKEX, , 2 caps daily use.
Placebo
The placebo capsule contains microcrystalline cellulose, 2 caps daily use.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* no disease, fatigue, or weakness
* independent and flexible activities
Exclusion Criteria
* BMI≧27
* Who have taken anti-inflammatory analgesics or acute and chronic diseases within one month, etc.,
* The students and related stakeholders guided by the host of this plan
* Who have the habit of smoking and drinking
* Within two weeks Have used probiotic products in powder, capsule or tablet form (including yogurt, yogurt, Yakult and other related foods)
* Food or allergic to lactic acid bacteria products
* Have had hepatobiliary and gastrointestinal surgery within 2 years (except hernia and polypectomy)
20 Years
39 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Grape King Bio Ltd.
INDUSTRY
National Taiwan Sport University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Chi-Chang Huang
Distinguished Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Graduate Institute of Sports Science, National Taiwan Sport University
Taoyuan District, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
22-022
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.